Quick Answer
REVELATION BIOSCIENCES, INC. reported Operating Income of -$9.07 million for fiscal year 2025.
REVELATION BIOSCIENCES, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$9.07M | -13.7% |
| 2024 | -$7.98M | +7.9% |
| 2023 | -$8.66M | +20.3% |
| 2022 | -$10.86M | +9.1% |
| 2021 | -$11.95M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.94M | -8.1% | +21.1% |
| June 30, 2025 | -$2.46M | +2.4% | -17.5% |
| March 31, 2025 | -$2.09M | -10.1% | -16.6% |
| September 30, 2024 | -$1.80M | +35.3% | +28.8% |
| June 30, 2024 | -$2.52M | -30.5% | -32.6% |
| March 31, 2024 | -$1.90M | -17.4% | +31.5% |
| September 30, 2023 | -$2.78M | -131.6% | -43.7% |
| June 30, 2023 | -$1.93M | -3.9% | -19.3% |
- REVELATION BIOSCIENCES, INC. showed a decrease of -13.7% in Operating Income compared to the prior fiscal year.
- Over the 2021–2025 period, REVELATION BIOSCIENCES, INC.’s operating income has grown by 24.1% (from -$11.95 million to -$9.07 million).
- The most recent figure is from REVELATION BIOSCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: